Member Info for roleybirkin

MOS get to understand revenue secured in different ways, and I believe the CEO has explained that when they announce a revenue number on/around the 1st March then that is in fact revenue gained across January.
Happy to be corrected on that above point?
I am hoping that we get a revenue update around 1st June which in reality would suggest what is known/gleaned and booked for April?
The company/Nomad may even suggest 1st August or thereabouts to be able to allow the company to deliver a June revenue number as the previous poster has suggested as it becomes more relevant to the companies reporting dates?

Either Four Quarters East at Here East (where the Bids team often drink) or a bar in the Shopping Centre….
I am easy.

Who is attending the AGM in person?
And drinks at what Bar?

Understand your point Pokerchips and agree, but revenue will be booked as revenue and costs (such as a percentage of revenues) will be booked as a cost of sale.

It may mean GFIN take longer than originally expected (this was noted in the last set of accounts) to get to break even but there will likely be revenue growth.

Guidance for 2022 (year to end June) ranges between £7m and £7.5m and I have taken a lowball number of £6.6m (two rimes 1H) and comfortable cheap at that level.

Overall, stocks like GFIN look cheap compared to many others being valued at 2.28 times 2021 revenues - similar sector BIDS is valued at almost 10 times 2021 revenues as an example.

Not trying to talk up GFIN. Just comfortable at this valuation .

The valuation is now a little over £13m which seems low given the interim revenue of £3.3m.
Assuming no growth for the 2H and the company would be announcing £6.6m for the year...
So the company is now valued on just 2 times the lowest revenue number likely.

What we also know is that January, February and then March all saw GDM unique views per month rise from Decembers 13.9m to March being around 17.5m so extremely positive.

All in all, the shares look cheap unless there is something we have not been told???

Totally agree, so watch this space?
My only concern is that the aggressor may be able to buy a BRSD at 20p or less which would be a steal.

I believe you are correct jc1220 and that is why they are complimentary to the standard cyber security companies whilst offering an extremely important and valid service.
It is also true to add that the BRSD technology is non intrusive and does not require any integration into a companies internal software systems which allows BRSD to sign up brands quickly and start to deliver value almost immediately.

The dividend is not a given.
Looking at the micro cap and nano cap markets this last 12 months one can only suggest that the NAV on the listed holdings has fallen significantly?
That said, I do feel that the unlisted portfolio have likely held previous valuations so not all bad.
I would prefer they conserve cash to take advantage of opportunities as there are more and more nano caps that require additional funding and the RGO model works superbly in tough times.

Logically, yes he would and I guess one could argue why would he or any shareholder sell unless the business growth slows or stops?
I am a small holder here and to date I like the opportunity.
Difficult market as we know but share price holding fairly well.

Yoav Keren
• 1st
CEO at BrandShield
now • Just now

I had a great time at the International Trademark Association (INTA) Annual Meeting 2022 along with several colleagues. It was all about chatting, networking and bringing up ideas around #brandprotection.

All in all a fantastic event - thanks to all those who stopped by for a chat!

Revenue on an ARR basis came in at $5.22m end 2021 or £4.18m with guidance at $6.80m through $7.25m…
I personally think undervalued but I agree that without decent communication to the market we are likely to fall further.

RNS was headed Placing Results and Trading update

Guidance for 2022 ranges from $6.80m - $7.25m - (£5.49m - £5.87m)
That would leave Brsd on an undemanding 2.08 to 1.99 times revenues...
Looks oversold.

Trading update was delivered end of January for 2021.
Revenue was $5.22m
130 clients signed
Strong pipeline of opportunities exist

This is indeed an encouraging win - as
1) It is to manufacture a virus
2) work should be completed by end Q3 so contract fully in 2022
3) further work likely to follow using the virus in some form of challenge study so a further payment may be forthcoming

ORPH should now be contracted fully for the guidance number of £50m for 2022 - maybe ahead of target and we are only at month 5 so the possibility of a renewed guidance number may be due at the half year mark?

Share certificates have been sent out from 27th April and the days following. If you have an account at a broker, they should be starting to process certificates received in the week ahead.
Bear in mind the share certificates have to be-
a) reconciled against the positions held within the broker
b) then dematerialised which can also take a few days and then
c) credited to investor accounts

Shares will be with you by mid May is my guess.

I am guessing that 'bending ma' may be Justin W... as he recently announced a stake above 3%.
Not sure he is selling given he is still putting out positive vibes?

New job position added. Presumably bodes well?

I finally got the name. It was so obvious you will all kick yourself…
Sleep tight one and all.

Interesting talking to one of Bids brokers - they seem to have two in Stifl and Cenkos - the revenue pencilled in to end June seems to be £2.6m...

That does suggest positive progress on 1H 2021 but also leaves the company wanting that 'strong second half'.

It is good to note that In-game ad's are gaining traction quickly and I hope to glean more at this afternoon's meeting with a competitor to Bids but always useful to see and hear what the sector is thinking.